Prime Offers Personalized Tool For Members to Save on Drugs
Prime Therapeutics LLC recently rolled out a tool that will help members proactively identify opportunities for saving money on drugs. The PBM joins multiple other companies offering the Rx Savings Solution platform...
New FDA Specialty Approvals
✦ Sept. 16: The FDA expanded the use of Roche’s CINtec PLUS Cytology test to help clinicians determine which women who test positive for human papillomavirus (HPV) via cobas 6800/8800 Systems require further dia...
News Briefs
✦ Teva Pharmaceuticals USA, Inc. launched the first generics of Gilead Sciences, Inc.’s Truvada (emtricitabine/tenofovir disoproxil fumarate) and Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate). ...
‘Buy American’ Executive Order Could Impact Specialty Drugs
President Donald Trump has issued another executive order focused on the pharmaceutical industry: a so-called “Buy American” order. While the approach presents some benefits, industry experts maintain that sever...
COVID Is Heating Up Payer Focus on Drug Pricing, Value
With the COVID-19 pandemic affecting a variety of health care stakeholders, the cost of these services is becoming even more important. Payers tightening their budgets are trying to make sure that they are truly pay...
Recently Approved Evrysdi May Have Big Impact on SMA Class
The spinal muscular atrophy (SMA) therapeutic category continues to expand with the Aug. 7 FDA approval of Evrysdi (risdiplam) from Roche Group member Genentech, Inc. Industry experts maintain that the drug has the ...
AllianceRx Walgreens Prime Unveils New Shipping Process
One common characteristic of specialty medications is that they require special handling. Quite often that means they need to remain refrigerated or frozen, which is critical while drugs are being transported to pat...
New FDA Specialty Approvals
✦ Aug. 5: The FDA gave accelerated approval to GlaxoSmithKline’s Blenrep (belantamab mafodotin-blmf) for adults with relapsed or refractory multiple myeloma who have received at least four prior therapies, inclu...
News Briefs
✦ Rep. Carolyn Maloney (D-N.Y.) said she plans to issue a subpoena to AbbVie Inc. for documents relating to Humira (adalimumab) and Imbruvica (ibrutinib). Maloney is the chairwoman of the Committee on Oversight an...
Impact of Executive Orders on Drug Pricing Is Questioned
On July 24, President Donald Trump signed four executive orders aimed at lowering what Americans pay for prescription drugs. Industry experts questioned how much of an impact two of the orders — one on low price i...
